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Background: Angiomyolipoma is a unique mesenchymal neoplasm composed of blood vessels as well as smooth
muscle and adipose cells. The liver is a less common site of origin, and hepatic angiomyolipoma is often an
incidental finding on diagnostic imaging or is identified on evaluation of nonspecific symptoms.
Case presentation: We experienced four patients who were diagnosed histologically with hepatic angiomyolipoma.
The preoperative diagnoses were angiomyolipoma in two patients, hepatocellular carcinoma in one, and cavernous
hemangioma in one. Three patients were treated with hepatectomy (one laparoscopic and two open approaches), and
the diagnosis was completed by histological investigation of the resected specimen. The remaining one was diagnosed
from tumor needle biopsy. Diffusion-weighted magnetic resonance imaging (MRI) with respiratory triggering using b
values of 0 and 800 s/mm2 was employed. An apparent diffusion coefficient map was generated from b values of 0 and
800 s/mm2 for calculation of the apparent diffusion coefficient. The apparent diffusion coefficient values were calculated
as 3.66, 1.21, 1.80, and 0.91 in patients 1 to 4, respectively. In MRI imaging, fat component was clearly demonstrated with
chemical shift imaging in three patients. Early venous return was detected in three patients with computed tomography
angiography.
Conclusion: Fat component and early venous return are important for a correct diagnosis of hepatic angiomyolipoma.
Unfortunately, apparent diffusion coefficient values in hepatic angiomyolipoma were overlapping with those in other
benign and malignant tumors.
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Angiomyolipoma (AML) is a unique mesenchymal neo-
plasm consisting of blood vessels, smooth muscle, and
adipose cells [1]. These neoplasms often arise in the
kidneys [2], while the liver is a less common site of ori-
gin; hepatic AML is often an incidental finding on diag-
nostic imaging or identified on evaluation of nonspecific
symptoms [3]. This tumor has been defined as a benign
neoplasm, although it is suggested that some cases may
have a malignant potential after hepatic resection [2,4,5].* Correspondence: hdobaba@kumamoto-u.ac.jp
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provided the original work is properly creditedDefinitive diagnosis is based on pathologic findings
supported by immunohistochemical staining. The
smooth muscle cell component is the most specific to
the diagnosis, and characteristically, these lesions stain
positive for homatropine methylbromide-45 (HMB-45)
and Melan-A [6,7]. Because hepatic AMLs are rare and
have various imaging features that overlap with those of
other tumors, definitive preoperative diagnosis is diffi-
cult to achieve, and more than half of the patients are
misdiagnosed with hepatocellular carcinoma (HCC) or
liver cell adenoma, which are much more common [8].
Magnetic resonance imaging (MRI) using conventional
and diffusion-weighted sequences has been introduced
as a valuable technique for the characterization of focal
solid hepatic lesions [9-11]. Nowadays, the apparentarticle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
Table 1 Clinical characteristics of the patients
Characteristics (n = 4) Finding
Gender (male/female) 3/1
Age (years) 72, 54, 51, 59
Symptom (positive/negative) 1/3
Diagnostic method (resection/biopsy) 3/1
HBs-Ag (positive/negative) 1/3
HCV-Ab (positive/negative) 0/4
Liver cirrhosis (positive/negative) 0/4
Child-Pugh (A/B) 4/0
Tumor diameter (mm) 12, 20, 22, 100
Number of tumor All solitary
Tumor markers
AFP (ng/ml) 2.7, 3.4, 3.9, 11.5
DCP (mAU/ml) 13, 24, 25, 28
CEA (ng/ml) 0.6, 1.0,1.3, 2.5
CA19-9 (U/ml) 1.0, 2.5, 3.3, 4.5
HBs-Ag, hepatitis B surface antigen; HCV, anti-hepatitis C virus antibody; AFP, alpha-
fetoprotein; DCP, des-gamma-carboxyl prothrombin; CEA, carcinoembryonic
antigen; CA19-9, carbohydrate antigen 19-9.
Table 2 Diagnostic imaging of the patients
Characteristics (n = 4) Finding




Plain CT - a heterogeneously low density
mass with low attenuation value (< −20 HU)
(yes/no)
2/2
Contrast-enhanced CT - early enhancement
with delayed washout (yes/no)
3/1
Not round margin, the tumor border was
irregular without capsular formation (yes/no)
1/3
Intratumoral vessels (yes/no) 2/2
Homogeneous enhancement (yes/no) 2/2
MRI
T1-weighted imaging (hypo/hyper/mixed) 2/1/1
T2-weighted imaging (hypo/hyper/mixed) 0/1/3
Fat component in chemical shift imaging (yes/no) 3/1
ADC in diffusion-weighted imaging 0.91/1.21/1.80/
3.66
Hypointensity in hepatobiliary phase on
T1-weighted imaging (Gd-EOB-DTPA) (yes/no)
2/0
Intratumoral vessels (yes/no) 1/3
Homogeneous enhancement (yes/no) 2/2
Dynamic CT, CT angiography, or MRI early venous
return (yes/no)
3/1
US, ultrasonography; CT, computed tomography; MRI, magnetic resonance
imaging; ADC, apparent diffusion coefficient; Gd-EOB-DTPA, gadolinium-
ethoxybenzyl-diethylenetriamine pentaacetic acid.
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quantitative measurements as an adjunct to diffusion-
weighted MRI (DW-MRI) [10,11].
The relationship among clinical behavior and radio-
logic and pathologic features is not well characterized in
this neoplasm [12,13]. There is a relatively small number
of reports about resected hepatic AML from outside of
China. The objective of this study was to characterize
four Japanese patients with hepatic AML evaluated to
determine radiologic characteristics by focusing on the
DW-MRI findings.
Case presentation
From 1997 to 2007, four patients were evaluated who
were diagnosed histologically with hepatic AML in the
Department of Gastroenterological Surgery, Kumamoto
University Hospital. All clinicopathological data were
collected in a prospective database. Radiologic data
were independently assessed by two radiologists. All
patients underwent ultrasonography (US), enhanced
computed tomography (CT), CT angiography, and
gadolinium-ethoxybenzyl-diethylenetriamine pentaace-
tic acid (Gd-EOB-DTPA)-enhanced or superparamag-
netic iron oxide (SPIO)-enhanced MR imaging. To
obtain a more correct preoperative diagnosis, we add-
itionally performed DW-MRI with respiratory trigger-
ing using b values of 0 and 800 s/mm2. An ADC map
was generated from b values of 0 and 800 s/mm2 for
calculation of ADC.
The clinical characteristics of the patients are summa-
rized in Table 1. Three patients treated with one laparo-
scopic [14] and two open hepatectomies were
histologically diagnosed from the resected specimen
and the remaining one from tumor needle biopsy. Only
one patient had a symptom of abdominal discomfort.
HBs-Ag was positive in one and HCV-Ab was negative
in all patients. All tumors were solitary, and tumor size
varied from 1.2 to 10 cm. Tumor markers were almost
in a normal range, but one patient showed a high
alpha-fetoprotein (AFP) level of 11.5 ng/ml (reference
range <7 ng/ml) before hepatic resection. The pre-
operative diagnoses were AML in two patients, HCC in
one, and cavernous hemangioma in one.
Diagnostic features are summarized in Table 2. Early
enhancement with delayed washout was clearly detected
in three patients, but the tumor border was irregular
without capsular formation (Figure 1). In MRI imaging,
fat component was clearly demonstrated with chemical
shift imaging in three patients. The ADC values were
calculated as 3.66, 1.21, 1.80, and 0.91 in patients 1 to 4,
respectively. Early venous return was detected in three
patients with CT angiography (Figure 2).
The diagnoses were confirmed histopathologically.
As the components of the smooth muscle cells and
Figure 1 A case of Gd-EOB-DTPA-enhanced MRI findings of huge AML. In the T1W in-phase image (A), the tumor itself is mixed intense in
hypointense surroundings. In the in-phase hyperintense signal areas (white arrow), the loose signal in the T1W out-of-phase image (B) is
consistent with the fat content (F). In the arterial phase image (C), a minor part of the tumor was remarkably enhanced (arrow) and this part
is consistent with meandering blood vessels (G). In DWI, (D) MRI displays an obvious hyperintense signal, whereas in the hepatobiliary phase
(E), it shows a homogenous hypointense signal. Major parts of the tumor are consistent with the smooth muscle cell component/components
(H), and these lesions were positive for HMB-45 and Melan-A.
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positive in all patients. Melan-A and αSMA, and Des-
min are positive in four and three patients, respect-
ively. There was no malignant AML. In three patientsundergoing hepatectomy, the operation time was 2.8,
7.8, and 8.5 h and intraoperative blood loss was 50,
870, and 1,580 g, respectively. All four patients are
alive without recurrence for 2.7 to 7.1 years.
Figure 2 A case of AML with early venous return. CT angiography via the left hepatic artery showed a patchy enhanced tumor in S3 with early
venous return to left hepatic vein (arrow).
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Multiple modalities have been used to diagnose hepatic
AML. Laboratory tests, viral markers for hepatitis,
tumor markers, and liver function have not been proven
to be specific or helpful in the diagnosis of hepatic
AML. Based on the large studies of hepatic AML [1,13],
only 23% to 50% of the patients could have been reliably
diagnosed before the operation.
It is because variable imaging appearances are due to
the varying proportion of three components: vessels,
smooth muscle cells, and adipose tissue.
In this study, fat component was demonstrated by
chemical shift MRI techniques in three patients. Identifi-
cation of signal drop on fat-saturated T1-weighted
sequences or opposed-phase chemical shift pulse se-
quences showed 100% specificity for the intratumoral fat
[6]. It is well known that HCC sometimes showed a
paradoxically high intensity in the hepatobiliary phase in
Gd-EOB-DTPA-enhanced MRI [15]; conversely, hepatic
AML never showed a high intensity. Early enhancement
with delayed washout, mimicking HCC, was clearly de-
tected in three patients, but the tumor border was
irregular without capsular formation. Besides, early ven-
ous return in the arterial or portal phase was detected
with various diagnostic imaging in three patients.
Kassarjian et al. [16] reported a classification of hepatic
hemangiomas with angiographic findings.
AML often contains a part of a hemangioma-like com-
ponent inside the tumor. All three patients in this study
demonstrated type 2 tumor, high-flow nodules, early fill-
ing of veins, and no visible direct shunts with no major
vascular anomalies. We were able to identify earlyvenous return in two patients only with CT angiography
but in the remaining one with standard enhanced CT.
The phenomena of early venous return might be useful
in differentiation with the other hepatic tumors and
caused early enhancement with delayed washout in the
hemangioma-like component. Lately, an early draining
vein has been reported to be seen in 73% of AML and
was suggested to be useful for distinguishing AML from
fat-containing HCC [12].
DW-MRI is sensitive to molecular diffusion and allows
for tissue characterization by probing tissue microstruc-
tural changes [9,10]. We believe that examination of
DW images in addition to routine abdominal MRI would
enhance diagnostic performance of radiologists during
evaluation of focal hepatic lesions.
Some studies [17,18] found that renal AML had sig-
nificantly lower ADC than renal cell carcinoma, cysts,
complicated cysts, and overall healthy parenchyma,
which stated diffusion-restricting muscle and fat compo-
nents as the causes for the decreased ADC of AML.
Thus, we assessed ADC for liver AML. In this study, to
obtain the true diagnosis of the tumor, we measured the
ADC value as a quantitative measurement as an adjunct
to DW-MRI [12]. We retrospectively examined 240 pa-
tients with 195 malignant (HCC, n = 137; liver metasta-
ses, n = 44; intrahepatic cholangiocarcinoma, n = 14) and
45 benign liver tumors (hemangioma, n = 37; focal nodu-
lar hyperplasia, n = 8). The mean ADC (×10−3 mm2/s) of
malignant tumors was 1.19 ± 0.30; for benign tumors,
this value was 1.98 ± 0.47. Unfortunately, the values of
AML were overlapping with those of other benign and
malignant tumors, and we could not find any differences
Kuramoto et al. Surgical Case Reports  (2015) 1:38 Page 5 of 6between the Japanese patients and non-Japanese
patients.
It has been reported that ADC measurements at three
different diffusion gradients may be a complementary
tool in the differential diagnosis of malignant and benign
tumors [11]. More recently, it has been demonstrated
that the ADC of the AML was significantly higher than
that of fat-containing HCC (1.92 ± 0.29 × 10−3 mm2/s vs
1.33 ± 0.25 × 10−3 mm2/s, p < 0.001).
AFP is a well-known tumor marker of HCC. Preopera-
tive AFP was positive in one patient who was diagnosed
with HCC before hepatic resection. We have reported
that preoperative AFP doubling time is a useful predictor
of recurrence and prognosis after hepatic resection of
HCC [19], but the AFP level in this patient did not in-
crease before hepatic resection and continued to have an
abnormal value postoperatively. Serial measurement is
useful to distinguish nonspecific elevation of a tumor
marker. In a patient without symptoms and risk factors
for liver malignancy (such as chronic hepatitis B or C
carrier, liver cirrhosis, alcohol abuse), with normal serum
tumor markers and with imaging features suggestive of
hepatic AML, conservative treatment with regular sur-
veillance has been recommended [13]. Recently, a malig-
nant AML in the liver was reported. To obtain a
definitive diagnosis of a liver tumor mimicking AML,
tumor needle biopsy is advocated. But if the tumor is lo-
cated at the surface of the liver, laparoscopic exploration
and biopsy is a preferred approach to avoid seeding of
tumor cells.
Conclusions
To obtain correct diagnosis of hepatic AML, evaluation
of fat component with chemical shift imaging in MRI
and early venous return in CT angiography is quite
beneficial. Furthermore, in the era of laparoscopic sur-
gery, laparoscopic liver resection is recommended for
minimally invasive total tumor biopsy [20]. ADC has
been recently reported as a useful marker to distinguish
AML and other liver tumors [12]. Further prospective
study comprising a large number of patients will be
required.
Consent
Written informed consent was obtained from the pa-
tients for the publication of this case report and any ac-
companying images.
Abbreviations
ADC: apparent diffusion coefficient; AFP: alpha-fetoprotein; AML: angiomyolipoma;
CT: computed tomography; DW-MRI: diffusion-weighted MRI; Gd-EOB-
DTPA: gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid; HBs-
A: hepatitis B surface antigen; HCC: hepatocellular carcinoma; HCV: anti-hepatitis C
virus antibody; HMB-45: homatropine methylbromide-45; MRI: magnetic
resonance imaging; SPIO: superparamagnetic iron oxide; US: ultrasonography.Competing interests
The authors declare that they have no competing interests.Authors’ contributions
KK and TB mainly participated in the conception, design, and analysis of this
case report and drafted the manuscript. TN, OI, and YY participated in the
diagnostic imaging analysis. KI participated in the histological analysis and
revised it. HH, KI, HN, DH, AC, and TI conceived of the study, participated in
its design and coordination, and helped to draft the manuscript. TB and HB
were responsible for this paper. All authors read and approved the final
manuscript.
Author details
1Department of Gastroenterological Surgery, Graduate School of Life
Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto City, Kumamoto
860-8556, Japan. 2Department of Multidisciplinary Treatment for
Gastroenterological Cancer, Kumamoto University Hospital, 1-1-1 Honjo,
Kumamoto City, Kumamoto 860-8556, Japan. 3Department of Diagnostic
Radiology, Graduate School of Life Sciences, Kumamoto University, 1-1-1
Honjo, Kumamoto City, Kumamoto 860-8556, Japan. 4Department of Surgical
Pathology, Kumamoto University Hospital, 1-1-1 Honjo, Kumamoto City,
Kumamoto 860-8556, Japan.
Received: 1 February 2015 Accepted: 9 April 2015
References
1. Tsui WM, Colombari R, Portmann BC, Bonetti F, Thung SN, Ferrell LD, et al.
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and
delineation of unusual morphologic variants. Am J Surg Pathol.
1999;23:34–48.
2. Zeng JP, Dong JH, Zhang WZ, Wang J, Pang XP. Hepatic angiomyolipoma: a
clinical experience in diagnosis and treatment. Dig Dis Sci. 2010;55:3235–40.
3. Prasad SR, Wang H, Rosas H, Menias CO, Narra VR, Middleton WD, et al. Fat-
containing lesions of the liver: radiologic-pathologic correlation. Radio-
graphics. 2005;25:321–31.
4. Takahara M, Miyake Y, Matsumoto K, Kawai D, Kaji E, Toyokawa T, et al. A
case of hepatic angiomyolipoma difficult to distinguish from hepatocellular
carcinoma. World J Gastroenterol. 2009;15:2930–2.
5. Chen P, Yuan T, Liu H. Hepatic angiomyolipoma mimicking hepatic clear
cell carcinoma. J Int Med Res. 2009;37:257–63.
6. Petrolla AA, Xin W. Hepatic angiomyolipoma. Arch Pathol Lab Med.
2008;132:1679–82.
7. Nonomura A, Mizukami Y, Takayanagi N, Masuda S, Ishii K, Tashiro K, et al.
Immunohistochemical study of hepatic angiomyolipoma. Pathol Int.
1996;46:24–32.
8. Jeon TY, Kim SH, Lim HK, Lee WJ. Assessment of triple-phase CT findings for the
differentiation of fat-deficient hepatic angiomyolipoma from hepatocellular
carcinoma in noncirrhotic liver. Eur J Radiol. 2010;73:601–6.
9. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M.
Separation of diffusion and perfusion in intravoxel incoherent motion MR
imaging. Radiology. 1988;168:497–505.
10. Namimoto T, Yamashita Y, Sumi S, Tang Y, Takahashi M. Focal liver masses:
characterization with diffusion-weighted echo-planar MR imaging.
Radiology. 1997;204:739–44.
11. Onur MR, Çiçekçi M, Kayalı A, Poyraz AK, Kocakoç E. The role of ADC
measurement in differential diagnosis of focal hepatic lesions. Eur J Radiol.
2012;81:e171–6.
12. Wang SY, Kuai XP, Meng XX, Jia NY, Dong H. Comparison of MRI features
for the differentiation of hepatic angiomyolipoma from fat-containing
hepatocellular carcinoma. Abdom Imaging. 2014;39:323–3.
13. Hu WG, Lai EC, Liu H, Li AJ, Zhou WP, Fu SY, et al. Diagnostic difficulties and
treatment strategy of hepatic angiomyolipoma. Asian J Surg.
2011;34:158–62.
14. Mima K, Beppu T, Chikamoto A, Ishiko T, Horino K, Hayashi N, et al.
Laparoscopy-assisted combined resection through the median mini-
laparotomy for undiagnosed liver tumor with ascending colon cancer:
report of a case. Surg Today. 2011;41:1633–8.
15. Lee SA, Lee CH, Jung WY, Lee J, Choi JW, Kim KA, et al. Paradoxical high
signal intensity of hepatocellular carcinoma in the hepatobiliary phase of
Kuramoto et al. Surgical Case Reports  (2015) 1:38 Page 6 of 6Gd-EOB-DTPA enhanced MRI: initial experience. Magn Reson Imaging.
2011;29:83–90.
16. Kassarjian A, Dubois J, Burrows PE. Angiographic classification of hepatic
hemangiomas in infants. Radiology. 2002;222:693–8.
17. Tanaka H, Yoshida S, Fujii Y, Ishii C, Tanaka H, Koga F, et al. Diffusion-weighted
magnetic resonance imaging in the differentiation of angiomyolipoma with
minimal fat from clear cell renal cell carcinoma. Int J Urol. 2011;18:727–30.
18. Sasamori H, Saiki M, Suyama J, Ohgiya Y, Hirose M, Gokan T. Utility of
apparent diffusion coefficients in the evaluation of solid renal tumors at 3 T.
Magn Reson Med Sci. 2014;13:89–95.
19. Masuda T, Beppu T, Horino K, Komori H, Imseung C, Hayashi H, et al.
Preoperative tumor marker doubling time is a useful predictor of recurrence
and prognosis after hepatic resection of hepatocellular carcinoma. J Surg
Oncol. 2010;102:490–6.
20. Beppu T, Hayashi H, Okabe H, Imai K, Nitta H, Masuda T, et al. Hybrid-including
endoscopic versus open hepatic resection for patients with hepatocellular
carcinoma meeting the Milan criteria: a propensity case-matched analysis.
Anticancer Res. 2015;35:1583–90.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
